Aktiesnakken — Maj 2011
-
Kan det være at genmab har løftet retorikken omkring lukning af zalut for at få refusion?
-
Men hvorfor har de ikke sagt dette før?
-
Det får de ikke noget ud af. Du kan ikke skræmme myndighederne ved at true med at lukke programmet
-
Jeg er på
Phone så skal lige trylle mig frem til rapporten. Kan du linke? -
Named patient er da en blåstempling fra myndighederne
-
Fluebenet må betyde det er lykkedes?
-
Hvordan kan det så reducerer kontantinvesteringen?
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind